CBD Life Sciences Inc CBDL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $0.00
- Volume/Avg
- 8.6 Mil / 6.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 3
- Website
- https://lbcbioscienceinc.com
Valuation
|
Metric
|
CBDL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CBDL
Financial Strength
|
Metric
|
CBDL
|
|---|---|
Quick Ratio | 5.22 |
Current Ratio | 5.22 |
Interest Coverage | — |
Quick Ratio
CBDL
Profitability
|
Metric
|
CBDL
|
|---|---|
Return on Assets (Normalized) | −16.20% |
Return on Equity (Normalized) | −108.95% |
Return on Invested Capital (Normalized) | −98.87% |
Return on Assets
CBDL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Vjq | $82.2 Bil | |
MKKGY
| Merck KGaA ADR | Zdxntsr | $75.8 Bil | |
HLN
| Haleon PLC ADR | Fjy | $38.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tbstq | $11.5 Bil | |
VTRS
| Viatris Inc | Cvchn | $11.2 Bil | |
CTLT
| Catalent Inc | Ckbzhy | $7.2 Bil | |
PRGO
| Perrigo Co PLC | Zms | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ztczb | $2.9 Bil | |
CURLF
| Curaleaf Holdings Inc | Qfhg | $2.6 Bil | |
GTBIF
| Green Thumb Industries Inc | Smt | $2.5 Bil |